With cancer rates top of mind for Iowans — given the state’s fastest-rising and second-highest cancer rate in the nation — the University of Iowa’s College of Pharmacy and Holden Comprehensive Cancer Center are partnering to create a new UI Institute for Cancer Drug Discovery and Development.

S5G Therapeutics received federal funding from the NIH to advance an antioxidant-based technology that may eventually lead to new eye drop treatments for dry eye disease, Fuchs endothelial corneal dystrophy, and other conditions involving oxidative stress.